Besides changes in RANKL/OPG levels, several cytokines (both pro- and anti-inflammatory) and chemokines are also increased in the blood from T1D subjects compared to controls, as shown by several serum proteomic studies (64–67). This evidence concerns the gene TNFRSF11B and type 1 diabetes mellitus.